All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Liraglutide 1.8mg: Side Effects

Side effects of liraglutide 1.8mg. Covers GI symptom rates, nausea management, headache, injection site reactions, and how side effects at this pivotal...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Side effects of liraglutide 1.8mg. Covers GI symptom rates, nausea management, headache, injection site reactions, and how side effects at this important dose compare to lower and higher levels.

The most common side effects of liraglutide 1.8mg are nausea (22 to 28 percent), diarrhea (10 to 15 percent), headache (8 to 13 percent), constipation (7 to 10 percent), and vomiting (6 to 10 percent). This dose represents the highest level used for diabetes (Victoza) and has years of safety data supporting its tolerability. For weight management patients titrating through 1.8mg, most GI side effects are brief and manageable, resolving within 2 to 4 days.

Side Effect Rates at 1.8mg: How They Stack Up

Side Effect 1.2mg 1.8mg 3.0mg
Nausea 18-25% 22-28% 39-40%
Diarrhea 8-12% 10-15% 20-21%
Constipation 5-8% 7-10% 19%
Vomiting 5-8% 6-10% 15-16%
Headache 7-12% 8-13% 13-14%
Decreased appetite 8-12% 12-18% 18-20%

The 1.8mg dose sits in the middle of the side effect range. Rates are moderately higher than at 1.2mg but substantially lower than at the full 3.0mg dose. This positioning makes 1.8mg a useful indicator of how you'll handle the higher doses ahead.

Nausea at 1.8mg: The Critical Transition

For many patients, 1.8mg is the dose where nausea is most noticeable during the titration process. This is because the 50 percent increase from 1.2mg is the largest proportional step remaining:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Liraglutide 1.8mg: Side Effects
  • Timing: Nausea typically appears within 24 to 48 hours of the first 1.8mg injection
  • Severity: Usually moderate. Stronger than what most patients felt at 0.6mg or 1.2mg, but rarely severe enough to prevent daily activities
  • Duration: 2 to 4 days for most patients. By day 5, the vast majority have adapted
  • Pattern: Often worst 2 to 4 hours after injection, then gradually fading

Management strategies at 1.8mg:

  • Take the injection just before bed so peak nausea occurs during sleep
  • Ginger supplements (250mg, 3 to 4 times daily) are effective for mild to moderate nausea
  • Eat small, frequent, bland meals. Crackers, rice, bananas, and plain chicken are well-tolerated
  • If OTC strategies fail, prescription ondansetron (4mg as needed) can bridge the transition
  • Avoid strong food smells, which can trigger nausea during the sensitive window

Managing nausea on liraglutide

Constipation at 1.8mg

At 1.8mg, the gastric-slowing effect becomes more pronounced. Constipation affects 7 to 10 percent of patients and can become a persistent issue if not managed proactively:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Cause: Liraglutide slows gastric emptying and intestinal motility. Combined with reduced food and water intake, this creates conditions for constipation.
  • Prevention: 25 to 30 grams of fiber daily (from vegetables, fruits, whole grains, or a supplement like psyllium husk), 64 to 80 ounces of water, and regular physical activity
  • Treatment: If prevention isn't enough, magnesium citrate (200 to 400mg at bedtime), MiraLAX (polyethylene glycol), or docusate sodium are effective options. Discuss with your prescriber if constipation persists beyond 3 to 4 days.

Injection Site Reactions

After three weeks of daily injections, injection site reactions may become a concern for some patients:

  • Small bruises, redness, or mild itching at the injection site affect 2 to 5 percent of patients
  • Rotating injection sites (abdomen one day, thigh the next, upper arm the third) helps prevent localized irritation
  • If you notice hardened areas (lipodystrophy) at frequently used sites, expand your rotation pattern
  • Using a fresh needle for each injection reduces skin irritation

Persistent or expanding injection site reactions should be reported to your prescriber.

Serious Side Effects to Monitor

While rare at any dose, these require prompt medical attention:

  • Pancreatitis: Severe, persistent abdominal pain (may radiate to the back), nausea, and vomiting. Stop liraglutide and seek immediate care.
  • Gallbladder disease: Pain in the upper right abdomen, especially after fatty meals. Risk increases with rapid weight loss.
  • Severe allergic reaction: Rash, itching, facial swelling, difficulty breathing. Seek emergency care immediately.
  • Thyroid warning: Liraglutide carries a boxed warning for thyroid C-cell tumors based on rodent studies. Report any neck swelling, difficulty swallowing, or persistent hoarseness.
  • Kidney injury: Severe dehydration from nausea and vomiting can affect kidney function. Report significantly decreased urination or persistent vomiting.

Frequently Asked Questions

Is 1.8mg the dose where most people decide to quit due to side effects?
No. The highest discontinuation rates in the SCALE trials occurred during the first month at the full 3.0mg dose, not during the titration. Most patients who make it through 1.8mg continue successfully. But if 1.8mg is truly intolerable, discuss alternatives with your prescriber before stopping entirely.
Will my side effects at 1.8mg predict what 3.0mg will be like?
Somewhat. If you have significant nausea at 1.8mg, you're more likely to experience nausea at 2.4mg and 3.0mg. But each subsequent increase is a smaller proportional step, so the side effects at higher doses often feel milder than what you experienced at 1.8mg. The worst is often behind you.
Should I take an extra week at 1.8mg?
If GI symptoms haven't resolved by day 7, an extra week is reasonable. If you're symptom-free and the daily routine is solid, proceed to 2.4mg on schedule. There's no benefit to lingering at 1.8mg if you're tolerating it well. liraglutide 1.8mg how long to stay on
Can I drink alcohol at 1.8mg?
In moderation, but be aware that liraglutide can affect blood sugar and alcohol tolerance. Some patients find that alcohol hits harder at 1.8mg than it did before treatment. Limit intake, avoid drinking on an empty stomach, and monitor how you feel. alcohol and GLP-1 medications

This article is for informational purposes only and doesn't constitute medical advice. Report any persistent or severe side effects to your prescriber.

Contact provider for current pricing Contact provider for current pricing

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Liraglutide 1.8mg: Side Effects custom 2026 header image for GLP-1 Weight Loss
Custom header image for Liraglutide 1.8mg: Side Effects, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Research guide
Page type
Research guide
Page metadata
Page updated
2026-04-01
Page metadata
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Liraglutide 1.8mg: Side Effects research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.